Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Olivia Arriaza"'
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:625-630
Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) indicated for treatment of chronic myeloid leukemia (CML). Dasatinib targets several proteins specific to cancer pathogenesis such as Bcr-Abl, Src, c-kit and PDGFRb. Cutaneous reactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46633124bc7cd4e96f8b130f3a0da99a
https://doi.org/10.25251/skin.7.1.13
https://doi.org/10.25251/skin.7.1.13
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::416a19fd7b7c7f90272cd19a08e9ea08
https://doi.org/10.1016/j.jaad.2022.06.817
https://doi.org/10.1016/j.jaad.2022.06.817